• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Only viable parasites are detected by PCR following clearance of rodent malarial infections by drug treatment or immune responses.在通过药物治疗或免疫反应清除啮齿动物疟疾感染后,只有活的寄生虫能通过PCR检测到。
Infect Immun. 1998 Aug;66(8):3783-7. doi: 10.1128/IAI.66.8.3783-3787.1998.
2
Real-time quantitative PCR for analysis of genetically mixed infections of malaria parasites: technique validation and applications.用于分析疟原虫基因混合感染的实时定量PCR:技术验证与应用
Mol Biochem Parasitol. 2003 Oct;131(2):83-91. doi: 10.1016/s0166-6851(03)00195-6.
3
Plasmodium chabaudi: reverse transcription PCR for the detection and quantification of transmission stage malaria parasites.查巴迪疟原虫:用于检测和定量传播期疟原虫的逆转录聚合酶链反应
Exp Parasitol. 2006 Jan;112(1):13-20. doi: 10.1016/j.exppara.2005.08.013. Epub 2005 Oct 27.
4
Mixed strain infections and strain-specific protective immunity in the rodent malaria parasite Plasmodium chabaudi chabaudi in mice.小鼠体内查巴迪疟原虫混合菌株感染及菌株特异性保护性免疫
Infect Immun. 2006 May;74(5):2996-3001. doi: 10.1128/IAI.74.5.2996-3001.2006.
5
The severity of malarial anaemia in Plasmodium chabaudi infections of BALB/c mice is determined independently of the number of circulating parasites.BALB/c小鼠感染查巴迪疟原虫时,疟原虫性贫血的严重程度与循环中的寄生虫数量无关。
Malar J. 2008 Apr 25;7:68. doi: 10.1186/1475-2875-7-68.
6
Amplified fragment length polymorphism measures proportions of malaria parasites carrying specific alleles in complex genetic mixtures.扩增片段长度多态性可测定复杂基因混合物中携带特定等位基因的疟原虫比例。
Mol Biochem Parasitol. 2004 Aug;136(2):117-22. doi: 10.1016/j.molbiopara.2004.02.011.
7
An AFLP-based genetic linkage map of Plasmodium chabaudi chabaudi.基于扩增片段长度多态性的沙巴疟原虫沙巴变种遗传连锁图谱。
Malar J. 2005 Feb 11;4:11. doi: 10.1186/1475-2875-4-11.
8
ICAM-1 is a key receptor mediating cytoadherence and pathology in the Plasmodium chabaudi malaria model.细胞间黏附分子-1(ICAM-1)是介导恰氏疟原虫疟疾模型中细胞黏附和病理过程的关键受体。
Malar J. 2017 May 3;16(1):185. doi: 10.1186/s12936-017-1834-8.
9
The activity and inhibition of the food vacuole plasmepsin from the rodent malaria parasite Plasmodium chabaudi.来自啮齿动物疟原虫查巴迪疟原虫的食物泡疟原虫蛋白酶的活性与抑制作用。
Acta Trop. 2006 Feb;97(2):212-8. doi: 10.1016/j.actatropica.2005.11.001. Epub 2005 Dec 5.
10
Relevance of undetectably rare resistant malaria parasites in treatment failure: experimental evidence from Plasmodium chabaudi.治疗失败中难以检测到的罕见抗药疟原虫的相关性:来自查巴迪疟原虫的实验证据。
Am J Trop Med Hyg. 2015 Jun;92(6):1214-21. doi: 10.4269/ajtmh.15-0036. Epub 2015 May 4.

引用本文的文献

1
Persistent and multiclonal malaria parasite dynamics despite extended artemether-lumefantrine treatment in children.尽管延长了青蒿琥酯-咯萘啶治疗,但仍存在持续性和多克隆疟原虫动态。
Nat Commun. 2024 May 7;15(1):3817. doi: 10.1038/s41467-024-48210-7.
2
Changing Clinical Epidemiology of Plasmodium vivax Malaria as Transmission Decreases: Population-Based Prospective Panel Survey in the Brazilian Amazon.随着传播减少,间日疟原虫疟疾的临床流行病学变化:巴西亚马孙地区基于人群的前瞻性面板调查。
J Infect Dis. 2024 Apr 12;229(4):947-958. doi: 10.1093/infdis/jiad456.
3
Intermittent preventive treatment with Sulphadoxine-Pyrimethamine (IPTp-SP) is associated with protection against sub-microscopic P. falciparum infection in pregnant women during the low transmission dry season in southwestern Cameroon: A Semi - longitudinal study.在喀麦隆西南部低传播旱季期间,磺胺多辛-乙胺嘧啶间歇性预防治疗(IPTp-SP)与孕妇免受恶性疟原虫亚显微感染的保护作用相关:一项半纵向研究。
PLoS One. 2022 Sep 30;17(9):e0275370. doi: 10.1371/journal.pone.0275370. eCollection 2022.
4
Difference between Microscopic and PCR Examination Result for Malaria Diagnosis and Treatment Evaluation in Sumba Barat Daya, Indonesia.印度尼西亚西帝汶省疟疾诊断与治疗评估中显微镜检查与PCR检测结果的差异
Trop Med Infect Dis. 2022 Jul 29;7(8):153. doi: 10.3390/tropicalmed7080153.
5
Malaria Diagnosis in Non-Endemic Settings: The European Experience in the Last 22 Years.非流行地区的疟疾诊断:过去22年的欧洲经验
Microorganisms. 2021 Oct 31;9(11):2265. doi: 10.3390/microorganisms9112265.
6
Recurrence of and Following Treatment of Uncomplicated Malaria in North Sumatera With Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine.在北苏门答腊使用双氢青蒿素哌喹或蒿甲醚本芴醇治疗单纯性疟疾后的复发情况。
Open Forum Infect Dis. 2020 Apr 2;7(5):ofaa116. doi: 10.1093/ofid/ofaa116. eCollection 2020 May.
7
Evaluation of residual submicroscopic Plasmodium falciparum parasites 3 days after initiation of treatment with artemisinin-based combination therapy.在开始使用基于青蒿素的联合疗法治疗 3 天后评估残留的亚微观疟原虫。
Malar J. 2020 Apr 21;19(1):162. doi: 10.1186/s12936-020-03235-3.
8
Malaria resurgence after significant reduction by mass drug administration on Ngodhe Island, Kenya.肯尼亚恩戈代岛大规模药物治疗后疟疾疫情反弹。
Sci Rep. 2019 Dec 13;9(1):19060. doi: 10.1038/s41598-019-55437-8.
9
Evaluation of PCR To Monitor Plasmodium falciparum Treatment Efficacy in a Nonendemicity Setting.评价 PCR 在非流行地区监测恶性疟原虫治疗效果的应用。
J Clin Microbiol. 2019 Dec 23;58(1). doi: 10.1128/JCM.01080-19.
10
A case of blackwater fever with persistent Plasmodium falciparum parasitaemia detected by PCR after artemether-lumefantrine treatment.伯氨喹啉治疗后疟原虫聚合酶链反应检测到恶性疟原虫持续性感染引起的黑尿热 1 例
Malar J. 2018 Jan 16;17(1):35. doi: 10.1186/s12936-018-2180-1.

本文引用的文献

1
The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment.聚合酶链反应基因分型在抗疟药物治疗后复发或再感染评估中的应用。
Parasitol Today. 1998 Nov;14(11):462-7. doi: 10.1016/s0169-4758(98)01340-4.
2
Distinction of recrudescences from new infections by PCR-RFLP analysis in a comparative trial of CGP 56 697 and chloroquine in Tanzanian children.在坦桑尼亚儿童中进行的CGP 56 697与氯喹对比试验中,通过聚合酶链反应-限制性片段长度多态性分析区分复发感染与新感染。
Trop Med Int Health. 1998 Jun;3(6):490-7. doi: 10.1046/j.1365-3156.1998.00253.x.
3
Measurement of Plasmodium falciparum growth rates in vivo: a test of malaria vaccines.恶性疟原虫体内生长率的测定:疟疾疫苗的一项试验
Am J Trop Med Hyg. 1997 Oct;57(4):495-500. doi: 10.4269/ajtmh.1997.57.495.
4
Treatment of African children with uncomplicated falciparum malaria with a new antimalarial drug, CGP 56697.用一种新型抗疟药CGP 56697治疗非洲单纯性恶性疟原虫疟疾患儿。
J Infect Dis. 1997 Oct;176(4):1113-6. doi: 10.1086/516524.
5
Simplified methodology for PCR investigation of midguts from mosquitoes of the Anopheles gambiae complex, in which the vector and Plasmodium species can both be identified.冈比亚按蚊复合体蚊子中肠PCR检测的简化方法,该方法可同时鉴定媒介和疟原虫种类。
Ann Trop Med Parasitol. 1997 Mar;91(2):217-9. doi: 10.1080/00034983.1997.11813132.
6
Plasmodium falciparum: sickle-cell trait is associated with higher prevalence of multiple infections in Gabonese children with asymptomatic infections.恶性疟原虫:镰状细胞性状与加蓬无症状感染儿童多重感染的较高患病率相关。
Exp Parasitol. 1997 Sep;87(1):39-46. doi: 10.1006/expr.1997.4173.
7
Daily dynamics of Plasmodium falciparum subpopulations in asymptomatic children in a holoendemic area.疟疾高度流行地区无症状儿童体内恶性疟原虫亚群的每日动态变化
Am J Trop Med Hyg. 1997 May;56(5):538-47. doi: 10.4269/ajtmh.1997.56.538.
8
Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine.氯喹和氨酚喹对恶性疟原虫pfmdr 1基因酪氨酸86等位基因进行选择的证据。
Parasitology. 1997 Mar;114 ( Pt 3):205-11. doi: 10.1017/s0031182096008487.
9
A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.一种抗恶性疟原虫疟疾的重组环子孢子蛋白疫苗的初步评估。RTS,S疟疾疫苗评估小组。
N Engl J Med. 1997 Jan 9;336(2):86-91. doi: 10.1056/NEJM199701093360202.
10
A method for the quantitative assessment of malaria parasite development in organs of the mammalian host.一种用于定量评估疟原虫在哺乳动物宿主机体器官中发育情况的方法。
Mol Biochem Parasitol. 1996 May;77(2):127-35. doi: 10.1016/0166-6851(96)02584-4.

在通过药物治疗或免疫反应清除啮齿动物疟疾感染后,只有活的寄生虫能通过PCR检测到。

Only viable parasites are detected by PCR following clearance of rodent malarial infections by drug treatment or immune responses.

作者信息

Jarra W, Snounou G

机构信息

Division of Parasitology, National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, United Kingdom.

出版信息

Infect Immun. 1998 Aug;66(8):3783-7. doi: 10.1128/IAI.66.8.3783-3787.1998.

DOI:10.1128/IAI.66.8.3783-3787.1998
PMID:9673262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC108417/
Abstract

Detection and analysis of pathogens by PCR plays an important role in infectious disease research. The value of these studies would be diminished if nuclear material from dead parasites were found to remain in circulation for extended periods and thus result in positive amplification. This possibility was tested in experimental rodent malaria infections. Blood samples were obtained from infected mice during and following drug or immune clearance of Plasmodium chabaudi chabaudi parasitemias. Detection of parasite DNA by a sensitive Plasmodium-specific PCR amplification assay was associated with the presence of viable parasites, as detected by subinoculation. No parasite DNA could be detected by PCR 48 h after the injection of killed parasites into mice. Nuclear material from parasites removed by drug or immune responses is rapidly cleared from the circulation and does not contribute significantly to amplification. Thus, results from PCR analysis of malaria-infected blood accurately reflect the presence of live parasites.

摘要

通过聚合酶链反应(PCR)检测和分析病原体在传染病研究中发挥着重要作用。如果发现来自死寄生虫的核物质在循环系统中长时间留存并因此导致阳性扩增,这些研究的价值将会降低。在实验性啮齿动物疟疾感染中对这种可能性进行了测试。在药物治疗或免疫清除恰氏疟原虫血症期间及之后,从受感染小鼠身上采集血样。通过灵敏的疟原虫特异性PCR扩增试验检测寄生虫DNA,与通过接种检测到的活寄生虫的存在相关。在向小鼠注射灭活寄生虫48小时后,PCR检测不到寄生虫DNA。药物或免疫反应清除的寄生虫的核物质迅速从循环系统中清除,对扩增没有显著贡献。因此,对疟疾感染血液进行PCR分析的结果准确反映了活寄生虫的存在。